Collectively, these multi-level and multi-dimensional findings strongly confirm that MAT exerts its therapeutic efficacy on the rheumatoid arthritis animal model through suppression of the NAV2-Wnt3a-β-catenin signaling cascade. This evidence concerns the gene WNT3A and rheumatoid arthritis.